Lilly product gets boost; Wall Street yawns
Eli Lilly and Co. probably will get approval for its newly acquired imaging agent used to diagnose Alzheimer’s disease, but so far analysts are unimpressed.
J.K. Wall
Articles
Q&A
Chris Sears is a health care and employee-benefits attorney at Ice Miller LLP in Indianapolis. He spoke about how employers are sizing up health insurance reforms that hit in 2014, which would set up government-subsidized insurance as a new option for workers but also would penalize most employers if they stop sponsoring employee health benefits.
Life sciences to drive Purdue’s next decade of building
Over the past 10 years, Purdue University has built Discovery Park into a thriving research and business incubation center, launching more than 30 companies and hosting dozens more. Now Purdue will spend more than $164 million to construct a Life and Health Sciences Quadrangle next to Discovery Park.
Mayor OKs school for students with learning disabilities
If approved by the City-County Council, the new Damar Charter Academy would open later this fall. It would specialize in students with significant cognitive, behavioral or developmental challenges, including those on the autism spectrum.
Class size takes back seat in education debate
In his State of the State address, Gov. Mitch Daniels called class size “virtually meaningless” in determining which kids succeed.
DeCoudreaux leaving Lilly for top job at Mills College
Alecia DeCoudreaux, the top attorney for Eli Lilly and Co.’s U.S. unit and an active community volunteer, will leave to become president of Mills College in California on July 1.
Evans dreams big as Clarian becomes IU Health
Clarian Health, which is set to change its name to Indiana University Health on Jan. 24, is relying on the academic expertise of its downtown Indianapolis hospitals to pull in patients from a wider swath of the state and the nation.
Down on luck, Lilly finds comfort in pets
Eli Lilly and Co. continues to misfire on getting new human medicines approved, but its animal health unit is on a roll.
Endocyte prices IPO stock
The West Lafayette-based drug development firm intends to sell 6.15 million shares for $13 to $15 apiece. That would fetch $80 million to $92 million.
Emmis surges as industry anticipates radio sale
Emmis Communications’ share price soared 42 percent on Wednesday, a day after the company reiterated that it is “actively pursuing” the sale of some assets. CEO Jeff Smulyan says it's impossible to call a station sale imminent, but shares gained another 13 percent on Thursday.
Can video games be good for your health?
Local companies are embedding stealthy video messages for high school and college students.
Roche back in court as partner looks to sell to competitor
Roche Diagnostics requested a temporary restraining order against Medical Automation Systems Inc. Tuesday after receiving word the company is speeding up plans to sell itself to Roche rival Alere Inc.
Deal could give Lilly full diabetes deck
Eli Lilly and Co.’s diabetes partnership with Boehringer Ingelheim GmbH represents a new kind of disease-focused strategy that some consultants think is key to pharma companies’ futures.
Q&A: Derek Bang
Derek Bang, practice leader of health care advisory services at the Crowe Horwath accounting firm in Indianapolis, spent a week in March studying health care in the United Kingdom, especially its universal health care program. He was surprised by the “daily barrage of criticism” he heard about the National Health Service, but also found that the United Kingdom and United States face very similar issues when it comes to constraining growth in health care costs.
UPDATE: Analysts praise Lilly diabetes deal with Boehringer
The deal Eli Lilly and Co. announced Tuesday morning with Boehringer Ingelheim GmbH sounded a lot like a baseball trade—with five drugs and payments to be named later—but analysts and investors generally liked what they heard.
Lilly agrees to pay up to $1.2B for diabetes drugs
A complex deal with Boehringer Ingelheim also gives the German company rights to two experimental Lilly insulins.
Tiny bank claims Stifel Nicolaus duped it on securities
The Peoples State Bank of Ellettsville says it was duped three years ago into investing more than $13 million into auction-rate securities just before those markets froze up. Now it’s suing its broker, Stifel Nicolaus & Co., to get the money back.
Evans exits mayor’s race, supports Kennedy
Democratic City-County Councillor Jose Evans follows Indianapolis businessman Brian Williams out of the race to challenge Republican Mayor Greg Ballard.
Roche aims to prevent bidding war for software firm
The Swiss company, which operates its North American business out of Indianapolis, filed a lawsuit late last month against Virginia-based Medical Automation Systems Inc. for breaching the purchase agreement the companies signed back in October.
Chamber props up graduation initiative
A cash crunch at its Common Goal education program forced the Greater Indianapolis Chamber of Commerce this month to start covering the program’s bills out of its coffers.